Your browser doesn't support javascript.
loading
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey
Soyer, Nur; Ali, Ridvan; Turgut, Mehmet; Haznedaroglu, Ibrahim Celalettin; Yilmaz, Fergün; Aydogdu, Ismet; Pir, Ali; Karakus, Volkan; Özgür, Gökhan; Kis, Cem; Ceran, Funda; Ilhan, Gül; Özkan, Melda; Aslaner, Müzeyyen; Ince, Idris; Yavasoglu, Irfan; Gediz, Füsun; Sönmez, Mehmet; Güvenç, Birol; Özet, Gülsüm; Kaya, Emin; Vural, Filiz; Sahin, Fahri; Töbü, Mahmut; Durusoy, Raika; Saydam, Güray.
Afiliación
  • Soyer N; Department of Hematology, Faculty of Medicine, Ege University, Izmir, Turkey
  • Ali R; Department of Hematology, Faculty of Medicine, Uludag University, Bursa, Turkey
  • Turgut M; Department of Hematology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
  • Haznedaroglu IC; Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
  • Yilmaz F; Department of Hematology, Atatürk Research and Training Hospital, Izmir, Turkey
  • Aydogdu I; Department of Hematology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey
  • Pir A; Department of Hematology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
  • Karakus V; Department of Hematology, Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey
  • Özgür G; Department of Hematology, Gülhane Research and Training Hospital, Ankara, Turkey
  • Kis C; Department of Hematology, Faculty of Medicine, Çukurova University, Adana, Turkey
  • Ceran F; Department of Hematology, Ankara Numune Research and Training Hospital, Ankara, Turkey
  • Ilhan G; Department of Hematology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey
  • Özkan M; Department of Hematology, Faculty of Medicine, Inönü University, Malatya, Turkey
  • Aslaner M; Department of Hematology, Dr. Ersin Arslan Research and Training Hospital, Gaziantep, Turkey
  • Ince I; Department of Hematology, Dr. Ersin Arslan Research and Training Hospital, Gaziantep, Turkey
  • Yavasoglu I; Department of Hematology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
  • Gediz F; Department of Hematology, Atatürk Research and Training Hospital, Izmir, Turkey
  • Sönmez M; Department of Hematology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
  • Güvenç B; Department of Hematology, Faculty of Medicine, Çukurova University, Adana, Turkey
  • Özet G; Department of Hematology, Ankara Numune Research and Training Hospital, Ankara, Turkey
  • Kaya E; Department of Hematology, Faculty of Medicine, Inönü University, Malatya, Turkey
  • Vural F; Department of Hematology, Faculty of Medicine, Ege University, Izmir, Turkey
  • Sahin F; Department of Hematology, Faculty of Medicine, Ege University, Izmir, Turkey
  • Töbü M; Department of Hematology, Faculty of Medicine, Ege University, Izmir, Turkey
  • Durusoy R; Department of Public Health, Faculty of Medicine, Ege University, Izmir, Turkey
  • Saydam G; Department of Hematology, Faculty of Medicine, Ege University, Izmir, Turkey
Turk J Med Sci ; 51(3): 1033-1042, 2021 06 28.
Article en En | MEDLINE | ID: mdl-33315343

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Mielofibrosis Primaria / Nitrilos Tipo de estudio: Observational_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Turk J Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Mielofibrosis Primaria / Nitrilos Tipo de estudio: Observational_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Turk J Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía